Hope For Newly Diagnosed Ovarian Cancer Patients– PARP Inhibitor Niraparib Now FDA Approved For Front-Line Ovarian Cancer Treatment

Updated May 25th, 2020

Hope For Newly Diagnosed Ovarian Cancer Patients– PARP Inhibitor Niraparib Now FDA Approved For Front-Line Ovarian Cancer Treatment

NOW
PLAYING
Mom Discovers Inoperable Cancer Six Months After Beating Disease
NOW
PLAYING
Pelé Hospitalized For Chemo Treatment In Colon Cancer Battle
NOW
PLAYING
Cancer Patient's Chemo Surgery Cancelled Three Times Due To COVID
NOW
PLAYING
Teacher Battling Stage IV Ovarian Cancer After Only Weeks of Symptoms
NOW
PLAYING
Rex Tillerson Thought Kidney Cancer Symptoms Were White House Stress
NOW
PLAYING
Mom Battles Breast Cancer Three Times Despite Double Mastectomy

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.